- Companies Developing Targeted Cancer Treatments Seek Higher Profits In 2013
- 3 Immunotherapy Companies That Have Learned Their Lessons Well
- The Volume Theory: Determining Which Stocks May Continue To Trade Higher
- Is Celldex Worth The Risk In 2013?
- 4 Companies With High Upside And Large Short Interest
Teresa Dawn
Teresa Dawn
Stop FollowingTeresa Dawn
ABOUT
I have been investing in the market for more than 30 years in small and midcap stocks. I have worked in the industry for almost 20 years in everything from IT to accounting, but am glad to say that I am now retired. This means I have time to share my knowledge with others!
SNAPSHOT
- Description: Accountant. Trading frequency: Weekly
- Interests: Stocks - long, Stocks - short
COMPANY
Currently, there is no company profile for Teresa Dawn.
BLOG
Currently, there are no blog details for Teresa Dawn.
Book
Currently, there are no book details for Teresa Dawn.
Latest Comments
more »
- Higher volume = more shares... on The Volume Theory: Determining Which Stocks May...
- Good info retiredpharma, th... on Is Celldex Worth The Risk In 2013?
- I know. I had already writt... on Is Celldex Worth The Risk In 2013?
- There are a lot. on 4 Companies With High Upside And Large Short In...
- I don't think they are nor ... on 4 Companies With High Upside And Large Short In...
Latest comments on Teresa Dawn's Articles
- hautefearbrandnewgod on Companies Developing Targeted Cancer Treatments...
- Gymnasia on Companies Developing Targeted Cancer Treatments...
- MonkeyBrain on Companies Developing Targeted Cancer Treatments...
- nohope on Companies Developing Targeted Cancer Treatments...
- joelkatz on Companies Developing Targeted Cancer Treatments...
LATEST ARTICLES & INSTAPOSTS
more »
